Regulatory T lymphocytes in myocardial infarction: A promising new therapeutic target

Ya Ping Wang, Yao Xie, Hong Ma, Sheng An Su, Yi Dong Wang, Jian An Wang, Mei Xiang Xiang*

*Corresponding author for this work

Research output: Contribution to journalLiterature reviewpeer-review

38 Citations (Scopus)

Abstract

Myocardial infarction (MI) is one of the leading causes of death especially in developed countries. Although the advent of early myocardial reperfusion therapy contributes to decreasing the mortality of patients with MI, cardiac ischemia-reperfusion injury and adverse remodeling during the repair process still remain the major factors impairing cardiac function and resulting in unsatisfactory prognosis. Excessive inflammation and immune responses play a crucial role during the whole process of MI. Regulatory T lymphocytes, characterized by immunosuppressive capacity, are associated with many immune-related diseases. Recent studies have proven a protective role of regulatory T cells in MI, which is mainly achieved by modulating inflammation and immune responses. In this review, we will summarize current knowledge of regulatory T lymphocytes, and highlight their roles in the onset of MI, ischemia-reperfusion injury, as well as post-infarct cardiac healing and remodeling.

Original languageEnglish
Pages (from-to)923-928
Number of pages6
JournalInternational Journal of Cardiology
Volume203
Early online date10 Nov 2015
DOIs
Publication statusPublished - 15 Jan 2016

Keywords

  • Ischemia-reperfusion injury
  • Myocardial infarction
  • Plaque instability
  • Regulatory T lymphocyte
  • Ventricular remodeling

Fingerprint

Dive into the research topics of 'Regulatory T lymphocytes in myocardial infarction: A promising new therapeutic target'. Together they form a unique fingerprint.

Cite this